Member Info for The.Italian

Https://www.biospace.com/article/ftc-s-challenge-to-amgen-horizon-merger-sparks-industry-attention/#:~:text=Amgen%27s%20acquisition%20of%20Horizon,Commission%20(FTC)%20in%20May. this presents an optimistic view of the likely outcome, but I've no idea how authoritative it is and whether ,for example, an appeal from the court's decision is possible,which would delay matters further. anyway, not long till october for news. im not overly familiar with the background to all this and apologies if there have been developments since june which may put a different perspective on matters. certainly one to keep an eye on .

Evening bignose. hope the move is going smoothly.

yes, perhaps i was being unduly negative, but it is all so frustrating .obviously i agree re US progress, although i think you will find they still the have same reference to a US deal as the last couple of times (page 21, last paragraph under the US commercialisation section), so that does just keep that hope alive.

anyway, news of china nda submission by end of september we hope.

Despite reading several times the convoluted(and dare i suggest deliberately obscure) description on pages 20 and 21 regarding the FDA application, i am none the wiser as to what has impeded the progress in reaching agreement on the SPA, which wax expected by end of q2 in the end of march results statement. i find it deeply disappointing that matters have not been clarified in any way. this issue is,imo,critical to the company's viability. to keep investors in the dark over this and to keep hiding behind vague and virtually meaningless assurances of positive progress and (feigned?) confidence, does a great disservice to those PIs who remain invested.

All just speculation,but i have been wondering how lombard see the endgame here. with a 28.5% holding they are not staying in to increase (i know there are whitewash provisions but in reality they are not likely to be in a position to invoke those in the absence of a corporate event justifying their application).so do they aim just to stay invested at this level indefinitely? possibly,but probably not imo. i assume they will be unable in practice to reduce their holding to any significant extent,even over time,as this would inevitably lead to a continuing s/p decline to the detriment of their retained holdings.so it would seem to make sense that they may be looking for a capital corporate event,e.g. a T/O, to unlock their value. this is why i am thinking more and more that a T/Oi s going to prove to be the determining event here. i imagine that ,on suitable terms,it would appeal to the board (generous consultancy agreements or directorships for example).barder is no spring chicken(i can say this as i am a lot older than he is) and may be glad to be relieved of the pressure of running a growing business and also the worry of things going awry. all this would,of course, depend on the product success in terms of sales, so next few weeks will be very interesting imo.

It seems clear from reviewing the latest statements,that there is no possibility of regent carrying on without some form of further financing. clearly no prospect of any US licensing agreement for some considerable time(if ever).china payment not going to happen till the earliest and of 2024.nothing of substance from DLI and so far as i can see virtually nothing from sales of fortacin in those few areas where they have been able to secure supply.looks like cash might last till feb or march of next year,but thereafter it looks pretty dire. can anyone suggest any reasons to be more optimistic?

Well not sure what to say.on first reading it seems pretty much a rehash of what was said last time.no clear information re spa just more of the same will re read,but basically feel we are no further forward.

Golden share went on the 21st june.no longer has any relevance for THG.

Morning bignose. yes, agree that DVP's decline will be in large part down to the negative messages coming out of china. in the long term i expect the demand for copper will prove to be very strong and resilient,so hopefully just a temporary unwelcome blip,but who knows.

yes interims at last.agree the excuse book will probably be in full play.my main worry is that we will find(however they dress it up )that the US is now dead in the water. lets hope i'm wrong.

yes,im also back im FUM (modest holding now though) as I've been thinking about the potential of the totality of world markets and think they may actually become a takeover target at some point.

no doubt there will be more to say in a few hours time.

Https://www.cityam.com/why-2023-has-been-a-year-to-forget-for-the-london-stock-exchange-and-the-capitals-equity-markets/ nothing thg specific, but interesting to see many of the regular tropes debated on here being reiterated in what is a quite comprehensive article.

Thank you laguito, for your response. i appreciate it. so just to be clear, futura itself has made no reference to an upcoming US trial,and your reference to it is based on your deductive reasoning,. it will be very interesting to see if you are correct in due course. if there is any such development i do think it would arouse considerable interest

Laguito,cal you point me in the direction, please, of fum's statement regarding its upcoming trial of med3000 in the us,nas i must have missed this.

Krull, the short answer to you question, is "no", but of course the question really is much more complex. there are, i think, 6 commercial deals in total and the terms will vary from one to another. fum and the licensees have different responsibilities and areas of operation,depending on which agreement one is looking at. the two main ones, coopers and haleon, appear to be very different,though we are,of course,only given bare outline details.i don't think any actual royalty figures have been given for any of them. in his last interview,f ollowing the haleon US deal, Barder mentions royalties and starts by saying they could have got a higher figure with another part (or perhaps parties), but decided to go with haleon because in the overall deal context they were the best party. he checks himself and qualifies his comments by saying that the haleon royalty figure is still a very decent royalty. this is my recollection and not a verbatim record of what he said, so suggest you listen to it yourself if you want to get it verbatim.

so overall,we don't have any figures for royalties,which will in some cases be tiered no doubt. whatever the figures are, they will need to be evaluated in the context of what are the respective responsibilities of each party. in the one agreement fum is being paid a fee for the supply and production of med 3000 for example, but we do not know how much this is or how it is calculated and how this affects their remuneration in other areas. what we do not yet know, and what we may not know for some time, is what is going to be the totality of remuneration from all the deals when they have been fully implemented.it is this that will,imo, ultimately determine what is the true value of med3000 and if there is a buyout ultimately (which i think is very possible as fum is a very small company) that will be based on that value. all just my opinion.

Agreed.pretty certainly a roll over.

Thanks for that bucolic.i actually burst out laughing when i read that.it's a shame that the ratings are being held down by obviously spurious re views,as whilst one would expect and accept some degree of negative reviews,there is clearly a significant element motivated by ill will towards the product/company.im back in by the way,as expecting a good response to results.only my opinion of course.

So 4 trading days now till interims.it will have been 5 months since any comment on the SPA process. i don't see how they can avoid saying something in the interims. if it is dead in the water surely they will have to come clean.hoping that is not the case,but not feeling confident.

Interesting to note the reference to 'no active ingredient"personally i doubt that this is a phrase that would readily spring to the mind of the average disappointed punter. it is of course a key phrase in the well known derampers lexicon! lol

Afternoon all. i hope you are wrong,bignose,re cash call but expect you are correct. only thing that could possibly prevent it would be an fda partner, but really can't see that happening now, with the continuing radio silence re SPA. looking like we may need to pin all our hopes on china.

Yes had same email.it states that the napster group holdings have been removed from my accounts,but this does not affect my entitlement to the tokens,as to which they will contact me when they have more detail..

Too true,bignose. certainly expected to have heard before now.not a good feeling..i see we have the interims' date now.

Interesting post re china.thanks.yes maybe that has taken a bit longer than expected. it's the fda position which really concerns me.still getting closer to interims day and some news at least.